Menu
GWAS Study

Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

Gudmundsson J, Sulem P, Gudbjartsson DF et al.

19198613 PubMed ID
GWAS Study Type
39547 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GJ
Gudmundsson J
SP
Sulem P
GD
Gudbjartsson DF
JJ
Jonasson JG
SA
Sigurdsson A
BJ
Bergthorsson JT
HH
He H
BT
Blondal T
GF
Geller F
JM
Jakobsdottir M
MD
Magnusdottir DN
MS
Matthiasdottir S
SS
Stacey SN
SO
Skarphedinsson OB
HH
Helgadottir H
LW
Li W
NR
Nagy R
AE
Aguillo E
FE
Faure E
PE
Prats E
SB
Saez B
MM
Martinez M
EG
Eyjolfsson GI
BU
Bjornsdottir US
HH
Holm H
KK
Kristjansson K
FM
Frigge ML
KH
Kristvinsson H
GJ
Gulcher JR
JT
Jonsson T
RT
Rafnar T
HH
Hjartarsson H
MJ
Mayordomo JI
DL
de la Chapelle A
HJ
Hrafnkelsson J
TU
Thorsteinsdottir U
KA
Kong A
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

In order to search for sequence variants conferring risk of thyroid cancer we conducted a genome-wide association study in 192 and 37,196 Icelandic cases and controls, respectively, followed by a replication study in individuals of European descent. Here we show that two common variants, located on 9q22.33 and 14q13.3, are associated with the disease. Overall, the strongest association signals were observed for rs965513 on 9q22.33 (OR = 1.75; P = 1.7 x 10(-27)) and rs944289 on 14q13.3 (OR = 1.37; P = 2.0 x 10(-9)). The gene nearest to the 9q22.33 locus is FOXE1 (TTF2) and NKX2-1 (TTF1) is among the genes located at the 14q13.3 locus. Both variants contribute to an increased risk of both papillary and follicular thyroid cancer. Approximately 3.7% of individuals are homozygous for both variants, and their estimated risk of thyroid cancer is 5.7-fold greater than that of noncarriers. In a study on a large sample set from the general population, both risk alleles are associated with low concentrations of thyroid stimulating hormone (TSH), and the 9q22.33 allele is associated with low concentration of thyroxin (T(4)) and high concentration of triiodothyronine (T(3)).

192 European ancestry cases, 37,196 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

39547
Total Participants
GWAS
Study Type
Yes
Replicated
432 European ancestry cases, 1,727 European ancestry controls
Replication Participants
European
Ancestry
U.S., Spain, Iceland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.